Billionaire Bill Ackman, Valeant Want To Takeover Botox-Maker Allergan - Presented by: The Aol. On Network

Activist hedge fund investor Bill Ackman may soon become an owner of Botox, the wrinkle-killing drug. According to a Wall Street Journal report, Ackman’s Pershing Square Capital is “teaming up” with Valeant Pharmaceuticals to pursue a takeover of Botox-maker Allergan. The news is sending shares of both public companies soaring. Valeant’s CEO Mike Pearson has said that it’s his goal to be among the world’s five biggest drugmakers within the next few years.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.16 0.64 ▲ 4.12%
EBAY $ 55.89 2.49 ▲ 4.66%
HPQ $ 37 1.88 ▲ 5.35%
INTC $ 35.15 0.65 ▲ 1.88%
JRJC $ 9.74 0.57 ▲ 6.22%
AAPL $ 100.58 0.01 ▲ 0.01%
HTZ $ 30.10 0.23 ▼ 0.76%
NOK $ 8.25 0.12 ▲ 1.48%

As of 8/21/2014, 04:03 PM
More Most Active